Now in its 22nd edition, this well-known text with more than 2 million copies in print has been the leading family planning reference for over 30 years.
At nearly 900 pages, Contraceptive Technology covers the field:
- Every contraceptive method, including for women with medical conditions
- The thorniest of clinical dilemmas in understanding risks and managing side effects
- Every STD, including a synopsis of CDC’s Sexually Transmitted Diseases Treatment Guidelines
- A systematic approach to menstrual disorders and contraception Insights into assessing abnormal pregnancies and risk of ectopic pregnancies
- New digital resources in reproductive health care, for you and for your patients
- Fertility awareness-based methods, including patient instructions and new technology
- Approaches to medication abortion
- Special considerations for teens, breastfeeding mothers, and menopausal women
Order today at:
Book preview...
Clinical Pearls
January 2022
… there can be a disconnect between the priorities of a caring provider and the priorities of the patient.
-- Shallini Ramanadhan
September 2021
…even with the ubiquity of STIs…most people (even health care providers) simply don’t feel comfortable discussing them. For most of us, having sex is much easier than talking about sex, especially its least pleasant consequences.
-- Ina Park MD, Strange Bedfellows
July 2021
…the majority of sexual activity during the reproductive years occurs during times when patients wish to avoid pregnancy.
-- Contraceptive Technology, 21st edition, p.678
June 2021
For individuals with chronic medical conditions, risks of pregnancy complications such as VTE, uncontrolled blood pressure, or stroke are increased.
-- Contraceptive Technology, 21st edition, p.549
May 2021
Sex shouldn’t hurt.
-- Noor Dasouki Abu-Alnadi, MD MS, 2021 – Contraceptive Technology virtual conference
March 2021
Vulvodynia can affect sexual identify, relationships with partners, and quality of life.
-- Contraceptive Technology, 21st edition
February 2021
“…if pain with sex is a reason for the choice of abstinence, it is the provider’s role to identify the source of pain and to try to resolve the symptoms.
-- Contraceptive Technology, 21st edition, p.425
January 2021
Patients’ serious mental illnesses (SMIs) have important implications for [their] family planning.
-- Contraceptive Technology 21st edition
November 2020
Findings about whether adherence is improved with the ring compared with the pill are mixed.
-- Contraceptive Technology 21st edition, p. 518
October 2020
…it’s incredibly important overall that we have different points of access as a way to protect reproductive health and rights in the current very challenging policy environment we face.
-- Maria Rodriguez, MD MPH, speaking at the Contraceptive Technology virtual conference, September 2020
September 2020
Watch the “QuickStart Guide” video on the ASCCP website at https://www.asccp.org/quickstart.
-- Michael Policar, Patty Cason
August 2020
Reproductive health providers, whose focus is often on patients’ health promotion and disease prevention, are uniquely well-suited to broach holistic discussions about patients’ overall health and psychological well-being as it influences sexual and reproductive health.
-- Contraceptive Technology, 21st edition, p. 718
July 2020
You are your safest sex partner.
-- New York City Department of Health and Mental Hygiene
May 2020
For many of us, the moral importance of our work is its most compelling appeal, and it helps sustain us in the face of political and economic challenges.
-- Felicia Stewart, 1943-2006, writing in Contraceptive Technology, 18th edition
April 2020
Although abstinence has become associated with saying “no,” viewed from another perspective, abstinence can mean saying “yes” to a number of other sexual activities and personal priorities.
-- Contraceptive Technology, p. 418
March 2020
Penile-vaginal intercourse is much more strongly associated with satisfying orgasm for the person with the penis than for the person with the vagina.
-- Contraceptive Technology, 21st edition, p. 669
February 2020
After having taken at least 7 COCs at the correct time, patients are at little risk for ovulation until they subsequently miss 7 consecutive pills.
-- Contraceptive Technology, 21st edition, p. 296
January 2020
Health care providers can assist our patients … by starting with a clear understanding of our role, which we propose is to help our patients figure out what they want and then help them get it.
-- Contraceptive Technology, 21st edition, p. 71
November 2019
Digital health resources have “transformed the provider-patient relationship such that HCPs are today not only responsible for providing information but also for guiding their patients’ search for and use of digital information.
-- Contraceptive Technology, 21st edition, p. 929
October 2019
Family planning providers, who are often the sole source of healthcare for reproductive-aged women, are uniquely well-suited to address interrelated mental and reproductive health needs.
-- Contraceptive Technology, 21st edition, p. 735
September 2019
While natural, sexuality is also cultural. Physiologic aspects of sexuality (for example, libido and arousal) are strongly linked with social and psychological factors.
-- Contraceptive Technology, 21st edition, p. 66
August 2019
Nearly 90% of cycling women experience some discomfort with their menses.
-- Contraceptive Technology, 21st edition, p. 45
July 2019
Technology fails people just as people fail technology…Contraceptive methods are imperfect and can fail even the most diligent user.
-- Contraceptive Technology, 21st edition, p. 111
June 2019
In younger individuals, the most common cause [of postcoital bleeding] is chlamydia cervicitis. In older individuals, benign lesions such as cervical polyps and more serious problems, such as cervical carcinoma, classically present with this type of bleeding.
-- Contraceptive Technology, 21st edition, p. 71
May 2019
Fluctuations in gonadotropins and estrogens seen during [perimenopause] are so dramatic that they have been described as “hormonal chaos.
-- Contraceptive Technology, 21st edition, p. 583
April 2019
The fact that the hypothalamus is affected by an array of neurotransmitters and other factors described above can help explain why stress, obesity, and medications can disrupt ovulatory cycling.
-- Contraceptive Technology, 21st edition, p. 46
March 2019
More than 80% of Fertility Awareness-Based methods (FABM) use in recent NSFG surveys is self-reported use of “rhythm.” So “lumped” estimates of effectiveness may not apply to individual FABMs.
-- Contraceptive Technology, 21st edition, p. 422
February 2019
The fact that the hypothalamus is affected by an array of neurotransmitters and other factors…can help explain why stress, obesity, and medications can disrupt ovulatory cycling.
-- Contraceptive Technology, 21st edition, p. 46
December 2018
Because implants and IUDs are highly effective, they are excellent choices for the short-term, too, and the fact that an implant or an IUD is good for “up to” 3 to 20 years is an added advantage but not always relevant.
-- Contraceptive Technology, 21st edition
November 2018
Given that the increase in maternal morbidity and mortality in the United States is due in part to chronic maternal conditions, providing appropriate contraceptive care is critical.
-- Contraceptive Technology, 21st edition, p.543
October 2018
Many of the resources listed in Contraceptive Technology represent sources that we believe will continue to be maintained by professional organizations and thus be updated to reflect the most current knowledge.
-- Contraceptive Technology, New 21st edition, p.947
September 2018
Ring use does not appear to have adverse effects on the cervico-vaginal epithelium or on cervical cytology
-- Contraceptive Technology, New 21st edition, p.237
August 2018
Once a pregnancy is visualized on ultrasound examination, then human chorionic gonadotropin hormone (hCG) testing is rarely useful.
-- Contraceptive Technology, upcoming 21st edition, in production
July 2018
The failure rate of every contraceptive method is lower in users over the age of 40 compared to younger individuals.
-- Contraceptive Technology, upcoming 21st edition, in production
June 2018
Placement of a copper IUD within 5 (or 7 or even 10) days after unprotected intercourse reduces the risk of pregnancy by more than 99%.
-- Contraceptive Technology, upcoming 21st edition, in production
May 2018
Overall, the full range of available contraceptive methods is appropriate for the majority of patients with depression and related conditions, including those taking SSRIs or SNRIs or using adjunct therapies.
-- Contraceptive Technology, upcoming 21st edition, in production
April 2018
COCs reduce the risk of ectopic pregnancy by 90%, a leading cause of maternal mortality in early pregnancy, because they substantially reduce the risk of pregnancy.
-- Contraceptive Technology, upcoming 21st edition, in preparation
February 2018
There are three national guidelines; each one says something different. All three agree that there is no evidence that the [screening pelvic exam] is beneficial. There is evidence of harms, including false alarms.
-- Contraceptive Technology, upcoming 21st edition, in preparation
January 2018
The Centers for Disease Control and Prevention’s Medical Eligibility Criteria and Selective Practice Recommendations website and mobile app … will have answers to most contraceptive questions healthcare providers might have when initiating contraceptives with their patients. These resources are also maintained regularly.
-- Contraceptive Technology, upcoming 21st edition, in preparation
December 2017
No contraceptive method is contraindicated on the basis of age alone.
-- Contraceptive Technology, upcoming 21st edition, in preparation
November 2017
Cumulatively, evidence supports the conclusion that once the implant is in place, it provides convenient, “forgettable,” ongoing pregnancy protection that is not affected by BMI.
-- Contraceptive Technology, upcoming 21st edition, in preparation
October 2017
All patients should be offered counseling and voluntary HIV testing, and those at risk should be linked to services that provide HIV PrEP. A useful resource is the PrEP in Family Planning Tool Kit, available at https://www.hiveonline.org/prep4familyplanning/.
-- Contraceptive Technology, upcoming 21st edition, in preparation
September 2017
Although abstinence has become associated with saying “no,” viewed from another perspective, abstinence can mean saying “yes” to a number of other sexual activities and personal priorities.
-- Contraceptive Technology, upcoming 21st edition, in preparation
August 2017
As more than 75% of patients will begin their search for health information by using popular search engines such as Google, Bing, or Yahoo, they may face difficulty in parsing out the most appropriate sources for their queries.
-- Contraceptive Technology, upcoming 21st edition, in preparation
July 2017
In a review of [the] literature, IUDs were placed up to 7 days after unprotected intercourse (UPI) in three studies, up to 10 days after UPI in one study, and up to 10+ days after UPI in one study; there were 0 pregnancies.
-- Contraceptive Technology, upcoming 21st edition, in preparation
June 2017
User instructions for progestin-only pills: “If you vomit within 4 hours after taking a pill, or if you have diarrhea…Keep taking the pills on schedule, but use a back-up method until 48 hours after vomiting or diarrhea are over.
-- Contraceptive Technology, p. 244
May 2017
…approximately 15% of clinical recognized pregnancies end spontaneously in early pregnancy…a prospective observational trial of 30 women having spontaneous abortion found success rates for expectant management are 82.1% at 2 weeks and 100% by 30 days…as long as the woman is stable.
-- Contraceptive Technology, p. 677
April 2017
When we counsel patients about birth control, help patients make decisions about an unintended pregnancy, help women plan for pregnancy and safely traverse its nine months…whether or not we are aware of it, we are engaged in a critically important and deeply moral undertaking.
-- Contraceptive Technology, p. xxiii
March 2017
Women with osteopenia have twice the risk for hip fracture…and women with osteoporosis have a nearly 9-fold increased risk.
-- Contraceptive Technology, p. 750
February 2017
Tubal infertility per PID episode: 8% after first episode; 20% after second episode; 40% after third episode.
-- Contraceptive Technology, p. 573
January 2017
The difference between pregnancy rates during typical use and pregnancy rates during perfect use reveals the consequences of imperfect use; this difference depends both on how unforgiving of imperfect use a method is and on how hard it is to use that method perfectly.
-- Contraceptive Technology, p. 49
December 2016
Although abstinence has become associated with saying “no,” viewed from another perspective, abstinence can mean saying “yes” to a number of other sexual activities…an abstinent person does not lose his or her sexuality…
-- Contraceptive Technology, p. 106-7
November 2016
The best approach to reducing the impact of [bleeding changes associated with using contraceptive implants] is to forewarn women about it emphasizing that it is generally not dangerous.
-- Contraceptive Technology, p. 198
October 2016
Low levels of hCG (5 to 30 mIU) may be associated with tumors of the pancreas, ovaries, breast, and many other sites. some normal postmenopausal women also have low levels of circulating hCG-like substance of pituitary origin.
-- Contraceptive Technology, p. 667
September 2016
… double-blind placebo-controlled trials have shown no difference in the incidence of any of the major side effects in COC users compared to pill users; similar percentages…developed headaches, nausea, vomiting, mastalgia excessive weight gain, etc. However, some women may be more sensitive to exogenous hormones, so counsel all potential hormonal contraceptive users that side effects may be possible but not necessarily to be expected.
-- Contraceptive Technology, p. 311
August 2016
Milk expression, such as by hand or pump, is not a substitute for breastfeeding in terms of its fertility-inhibiting effect.
-- Contraceptive Technology, p. 487
July 2016
When a woman has had unprotected sex, we can offer her an intrauterine contraceptive rather than emergency contraceptive pills. Placement of the IUD within several days of unprotected sex reduces a woman’s risk of pregnancy to about 1 in 1,000 and providers her with 10 to 20 years of highly effective, fully reversible contraception…
-- Contraceptive Technology, p. xxvi
June 2016
… severe diarrhea can decrease your body’s ability to absorb the pill’s hormone. If you have vomiting or diarrhea, treat it as if you had missed pills.
-- Contraceptive Technology, p. 322
May 2016
Breastfeeding has a major protective effect against premenopausal cancers of the ovary, endometrium, and breast and protects against type 2 diabetes.
-- Contraceptive Technology, p. 501
April 2016
For some areas of clinical medicine, the why seems hardly to need articulating…The value of work as a heart disease clinician [for example] is not likely to be attacked as immoral…Unfortunately, tis is not true for clinicians working in the field of family planning services and reproductive health.
-- Felicia Stewart, MD, in Contraceptive Technology, p. xxiii
March 2016
More frequently, women with [heavy menstrual bleeding] have functional problems with excessive endometrial fibrinolysis, a prostaglandin imbalance, vessel instability, or inhibition of matrix metalloproteinase activity. only about half of women with heavy menstrual bleeding have an anatomical pathology…
-- Contraceptive Technology, p. 548
February 2016
The conditions that cause secondary amenorrhea…also commonly cause infrequent menses. Once pregnancy is ruled out, most cases are round to be associated with estrogen production but with a lack of progesterone.
-- Contraceptive Technology, p. 541
December 2015
“IUC use appears safe and effective for women who are immunosuppressed due to organ transplantation, autoimmune disease, or infection with HIV. IUC use has not been shown to increase viral shedding, and clinical HIV disease progression was slower among women using the TCU380A than among women using hormonal contraception.
-- Contraceptive Technology, p. 159
November 2015
Ovulation can occur even though the breastfeeding mother has not yet resumed menstruation…33-45% during the first 3 months postpartum; 64-71% during months 4 through 12; 87-100% after 12 months.
-- Contraceptive Technology, p. 486
October 2015
…the risk of infection and infertility among IUC users is very low. …the placement process, and not the device or its thread, poses a small transient risk of infection… However, antibiotic prophylaxis should not be routinely used before placement.
-- Contraceptive Technology, p. 156
September 2015
…insulin resistance in women with polycystic ovarian syndrome does not predictably worsen with COC use.
-- Contraceptive Technology, p. 287
August 2015
Risk of death (per year). Using combined oral contraceptives (and presumably the path and ring) for nonsmokers aged 15-34: 1 in 1,667,000 / From an automobile accidents: 1 in 5,000 / From a fire: 1 in 20,000 / In an airplane crash: 1 in 250,00.
-- Contraceptive Technology, back inside cover
July 2015
Most studies show that during vaginal sex, condoms break approximately 2 percent of the time during intercourse or withdrawal and a similar proportion slip off completely…advise users to have several condoms available in case a condom is torn or put on incorrectly…
-- Contraceptive Technology, p. 380
June 2015
The risk of VTE [venous thromboembolism] with COCs [and other hormonal contraceptives] is greatest in the first 3 to 12 months of use and declines thereafter.
-- Contraceptive Technology, p. 277
May 2015
COC use increases bone mineral density (BMD) in … anorexic teenagers. COC use by women with osteopenia due to anorexia nervosa is not sufficient to completely protect bone, but when added to anabolic agents such as insulin growth factor, COC use significantly improves that agent’s effectiveness.
-- Contraceptive Technology, p 270
April 2015
Preventing pregnancy is generally safer than pregnancy. Compare the risk of death associated with using combined hormonal contraceptives with the risk of death associated with pregnancy:
- Pregnancy: 1 in 6,700
- Nonsmokers: the risk for women aged 15-34 is 1 in 1,667,000 and for women aged 35-44 it is 1 in 33,000.
Smokers: the risk for women aged 15-34 is 1 in 57,800 and for women aged 35-44 it is 1 in 5,200.
-- Contraceptive Technology, inside back cover
March 2015
Women using ACE inhibitors, angiotensin-II antagonists, potassium-sparing diuretics, heparin, aldosterone antagonists, and NSAIDS on a chronic daily basis to treat chronic conditions or diseases should have their serum potassium checked during the first cycle of drospirenone use (usually about 14 days after pill initiation). If those levels are normal, no future testing is necessary.
-- Contraceptive Technology, p. 308
February 2015
In a study of high-school students who consider themselves virgins, 30% had engaged in heterosexual masturbation of or by a partner, 9% had engaged in fellatio (oral-penile contact) with ejaculation, and 10% had engaged in cunnilingus (oral-female genital contact).
-- Contraceptive Technology, p. 102
January 2015
Women with continued spotting or bleeding following their scheduled bleeding may need more estrogen to proliferate the endometrium. Increase the estrogen to proliferate the endometrium. increase the estrogen in the first pills in the pack or decrease the progestin content of those first pills.
-- Contraceptive Technology, p. 313
December 2014
…probabilities of pregnancy cumulate over time. For example, suppose that each year the typical proportion of women becoming pregnant while taking the pill is 8%…Within 5 years [of pill use], 34%…will become pregnant.
-- Contraceptive Technology, p. 55
November 2014
In terms of contraceptive service delivery, routine adherence to the 6-week convention does not seem appropriate…Although nearly all contraceptive methods can be used postpartum, the methods vary in terms of when in postpartum period they should be initiated. 6 weeks is too late to begin contraceptive for nonbreastfeeding mothers who wish to start using [hormonal methods]; 3 weeks is too soon for inserting an IUC…
-- Contraceptive Technology, p. 490
October 2014
Unintended pregnancy/coital act: 17%-30% midcycle, <1% during menses.
-- Contraceptive Technology, p. 573
September 2014
Among nonmarried women, 32% reported they had not had sex in the past year, 25% reported only a few times in the past year, 26% reported a few times in the past month, and 26% reported two or more times per week.
-- Contraceptive Technology, p. 5
August 2014
Most women wish to discuss sexual concerns but report that most providers neither inquire about nor follow up on sexual issues…
-- Contraceptive Technology, p. 2
July 2014
While there is considerable variation in cycle length, less than 1% of women have a regular cycle length of less than 21 days or more than 35 days.
-- Contraceptive Technology, p. 30
June 2014
Leiomyoma (uterine fibroids) contain both estrogen and progesterone receptors…However, clinical studies with low-dose COCs have found no impact on the risk of developing new fibroids or on increasing the size of pre-existing fibroids, except in women who used COCs early in life.
-- Contraceptive Technology, p. 287
May 2014
While chronic daily use of some drugs may increase serum potassium in some women using drospirenone-containing contraceptive pills, note that intermittent use of NSAIDS does not pose any problems. If a woman is using other potassium-sparing drugs, test her potassium about 14 days after starting her first pack; if that value is normal, no further testing is needed for potassium.
-- Contraceptive Technology, p. 287-88
April 2014
The typical woman who uses reversible methods of contraception continuously from age 15 to age 45 would experience 1.8 contraceptive failures.
-- Contraceptive Technology, p. 55
March 2014
The protective effect of transabdominal tubal sterilization on ovarian cancer persists over many years…The risk remained low up to 25 years after surgery and was irrespective of sterilization technique.
-- Contraceptive Technology, p. 441
February 2014
What about new contraceptives for men? Except for gossypol, no method has been developed sufficiently for clinical studies.
-- Contraceptive Technology, p. 525
January 2014
…we need to convey not only the science of reproductive health, but also why it is of vital importance in people’s lives…If we fail to do so, we are abdicating the moral high ground to those who oppose efforts to provide reproductive health care.
-- Felicia Stewart, MD (1943-2006)
December 2013
IUCs [intrauterine contraceptives] protect women from ectopic pregnancy…However when a woman does conceive with an IUC in place she is at increased risk of having an ectopic pregnancy…6% to 50% of pregnancies are ectopic.
-- Contraceptive Technology, p. 157
November 2013
…antibiotic prophylaxis should not be routinely used before placement [of an intrauterine device].
-- Contraceptive Technology, p. 156
October 2013
Spermatozoa appear in the pre-ejaculatory fluid of some men and could cause pregnancy even if the man withdraws prior to ejaculation.
-- Contraceptive Technology, p. 409
September 2013
…a women’s blood loss is excessive when she says it is excessive…the key factor in making a diagnosis of [heavy menstrual bleeding] is not the amount of blood a woman loses, which is difficult to ascertain, but how a woman’s HMB disrupts her life.
-- Contraceptive Technology, p. 547
November 2023
“Reproductive health care enables individuals and couples to make and implement some of the most important decisions that shape their lives, and that also shape society.”
-- —Felicia Hance Stewart (1943-2006), 18th Edition of Contraceptive Technology